Liu, Zoe Shih-Jung
Sattabongkot, Jetsumon
White, Michael
Chotirat, Sadudee
Kumpitak, Chalermpon
Takashima, Eizo
Harbers, Matthias
Tham, Wai-Hong
Healer, Julie
Chitnis, Chetan E.
Tsuboi, Takafumi
Mueller, Ivo
Longley, Rhea J.
Funding for this research was provided by:
National Health and Medical Research Council (#1092789, #1134989, #1043345, #1143187)
National Health and Medical Research Council (#1173210)
Global Health Innovative Technology Fund (T2015-142)
National Institute of Allergy and Infectious Diseases (5R01 AI 104822)
Howard Hughes Medical Institute
Melbourne Research, University of Melbourne
Article History
Received: 2 November 2021
Accepted: 2 February 2022
First Online: 9 March 2022
Declarations
:
: Collection of the Thai symptomatic longitudinal study in Tha Song Yang, Tak Province, was approved by The Ethics Committee of the Faculty of Tropical Medicine, Mahidol University, Thailand (MUTM 2014-025-01 and -02). For the Thai asymptomatic cohort study in the Kanchanaburi and Ratchaburi provinces, collection of samples was approved by The Ethics Committee of the Faculty of Tropical Medicine, Mahidol University, Thailand (MUTM 2013-027-01). The Human Research Ethics Committee (HREC) at the Walter and Eliza Hall Institute of Medical Research (WEHI) approved the use of these samples in Melbourne (#14/02). The collection and/or use of the 3 malaria-free control panels in Melbourne were approved by the HREC at WEHI (#14/02). All individuals provided informed consent and/or assent.
: Not applicable.
: R.J.L., M.W., T.T., and I.M. are inventors on patent PCT/US17/67926 on a system, method, apparatus and diagnostic test for <i>Plasmodium vivax.</i> MH was employed by company CellFree Sciences Co., Ltd. The remaining authors declare no conflict of interest.